Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,094 public trials 2,044 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT01456689

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Ann Arbor, Michigan, United States
  • Novartis Investigative Site Rochester, Minnesota, United States
  • Novartis Investigative Site Houston, Texas, United States
View Trial Details
Completed

Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma

NCT01956695

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Centre Léon Bérard Lyon, Auvergne-Rhône-Alpes, France
  • CHU Estaing Clermont-Ferrand, Auvergne, France
  • CHU Bretonneau - Centre Henry Kaplan Tours, Centre-Val de Loire, France
  • Institut Bergonié Bordeaux, Gironde, France
View Trial Details
Completed

Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma

NCT01275209

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Dana Farber Cancer Institute SC-5 Boston, Massachusetts, United States
  • Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States
  • Duke University Medical Center Duke Hem & Onc Durham, North Carolina, United States
  • Sarah Cannon Research Institute SC - 2 Chattanooga, Tennessee, United States
View Trial Details

Related conditions